c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP ‐treated diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP ‐treated diffuse large B‐cell lymphoma

Published:2021-08-09 Issue:6 Volume:7 Page:604-615
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Bouroumeau Antonin¹²³,Bussot Lucile⁴,Bonnefoix Thierry²⁵,Fournier Cyril⁶⁷,Chapusot Caroline⁸,Casasnovas Olivier⁹,Martin Laurent⁸,McLeer Anne¹²,Col Edwige¹,David‐Boudet Laurence¹,Lefebvre Christine¹⁰,Algrin Caroline¹¹,Raskovalova Tatiana¹⁰,Jacob Marie‐Christine¹⁰,Vettier Claire¹⁰,Chevalier Simon¹⁰,Callanan Mary B⁶⁷,Gressin Rémy⁴,Emadali Anouk²⁵,Sartelet Hervé¹¹²^ORCID

Affiliation:

1. Department of Pathology Grenoble‐Alpes University Hospital Grenoble France

2. Institute for Advanced Biosciences INSERM U1209/CNRS UMR 5309/Grenoble‐Alpes University Grenoble France

3. Division of Clinical Pathology, Diagnostic Department Hôpitaux Universitaires Genève Geneva Switzerland

4. Department of Clinical Hematology Grenoble‐Alpes University Hospital Grenoble France

5. Pole Recherche Grenoble‐Alpes University Hospital Grenoble France

6. University of Bourgogne, INSERM 1231 Dijon France

7. Unit for Innovation in Genetics and Epigenetics in Oncology Dijon University Hospital Dijon France

8. Department of Pathology Dijon University Hospital Dijon France

9. Department of Clinical Hematology Dijon University Hospital Dijon France

10. Hematology, Oncogenetics and Immunology Unit Grenoble‐Alpes University Hospital Grenoble France

11. Institut Daniel Hollard Grenoble France

12. Department of Pathology Nancy Regional University Hospital Nancy France

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.223

Reference61 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

3. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

4. Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network

5. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets;American Journal of Cancer Research;2024

2. Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma;Human Pathology;2023-09

3. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma;Cancer Management and Research;2023-07

4. Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma;Cancers;2023-05-13

5. Prognostic impact of miR-125b and miR-155b and their relationship with <i>MYC</i> and <i>TP53</i> in diffuse large B-cell lymphoma: cell-of-origin classification matters;Journal of Clinical and Experimental Hematopathology;2023